In adult CHD patients undergoing CABG, perioperative use of GLP-1 receptor agonists was associated with a significant reduction in one-year hospital readmission rates, without increased risk of mortality, postoperative complications, or known GLP-1-related adverse events. The gene discussed is GLP1R; the disease is coronary artery disorder.